Global MRD Detection Supply, Demand and Key Producers, 2023-2029

Global MRD Detection Supply, Demand and Key Producers, 2023-2029

The global MRD Detection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

MRD (Minimal Residual Disease) refers to the state of a small amount of tumor cells remaining in the body after treatment of malignant tumors, which is the root cause of tumor recurrence. Accurate MRD detection is the basis for personalized precision medicine for patients.

This report studies the global MRD Detection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for MRD Detection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of MRD Detection that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global MRD Detection total production and demand, 2018-2029, (K Units)

Global MRD Detection total production value, 2018-2029, (USD Million)

Global MRD Detection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global MRD Detection consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: MRD Detection domestic production, consumption, key domestic manufacturers and share

Global MRD Detection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global MRD Detection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global MRD Detection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global MRD Detection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Neoimmune, Labcorp Inc, F.Hoffmann-La Roche Ltd., GuardantHealth, Sysmex Corporation, NeoGenomics Laboratories, Inc., Adaptive

Biotechnologies Corporation, ArcherDX, Inc. and Asuragen Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World MRD Detection market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global MRD Detection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global MRD Detection Market, Segmentation by Type
Flow Cytometer
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)

Global MRD Detection Market, Segmentation by Application
Scientific Research Unit
Medical School
CDC
Other

Companies Profiled:
Neoimmune
Labcorp Inc
F.Hoffmann-La Roche Ltd.
GuardantHealth
Sysmex Corporation
NeoGenomics Laboratories, Inc.
Adaptive

Biotechnologies Corporation
ArcherDX, Inc.
Asuragen Inc.
Arup Laboratories Inc.
Bio-Rad Laboratories
Opko Health
Quest Diagnostics
ICON plc
Cergentis B.V.

Key Questions Answered

1. How big is the global MRD Detection market?

2. What is the demand of the global MRD Detection market?

3. What is the year over year growth of the global MRD Detection market?

4. What is the production and production value of the global MRD Detection market?

5. Who are the key producers in the global MRD Detection market?

6. What are the growth factors driving the market demand?